|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
AU2001248701A1
(en)
|
2000-03-24 |
2001-10-03 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
JPWO2002074298A1
(ja)
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
CA2463821A1
(en)
|
2001-11-01 |
2003-05-08 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
CA2518318A1
(en)
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2005097747A1
(en)
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
CN101495116A
(zh)
|
2005-03-22 |
2009-07-29 |
哈佛大学校长及研究员协会 |
蛋白降解病症的治疗
|
|
EP1940805A4
(en)
|
2005-08-26 |
2009-11-11 |
Methylgene Inc |
BENZODIAZEPIN AND BENZOPIPERAZINANALOGA AS INHIBITORS OF HISTONDEACETYLASE
|
|
AU2007345292B2
(en)
|
2006-02-14 |
2013-10-31 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
US20100278782A1
(en)
|
2006-06-12 |
2010-11-04 |
Vrije Universiteit Brussel |
Differentiation of rat liver epithelial cells into hepatocyte-like cells
|
|
ES2288802B1
(es)
|
2006-07-07 |
2008-12-16 |
Universidad De Granada |
Nuevos derivados de ftalimida como inhibidores de las histonas desacetilasas.
|
|
AU2007296743B2
(en)
|
2006-09-11 |
2012-02-16 |
Curis, Inc. |
Tyrosine kinase inhibitors containing a zinc binding moiety
|
|
KR101325374B1
(ko)
|
2008-02-19 |
2013-11-08 |
가부시키가이샤 오츠까 세이야꾸 고죠 |
신체 기능의 회복에 유용한 경구 또는 경장 조성물
|
|
RU2515611C2
(ru)
|
2008-07-23 |
2014-05-20 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Ингибиторы деацетилазы и их применение
|
|
US8716326B2
(en)
|
2009-05-15 |
2014-05-06 |
Korea Research Institute Of Chemical Technology |
Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
EP2638009A4
(en)
|
2010-01-08 |
2014-06-11 |
Harvard College |
FLUORINATED HDAC HEMMER AND USES THEREOF
|
|
TWI600638B
(zh)
*
|
2010-01-22 |
2017-10-01 |
艾斯特隆製藥公司 |
作爲蛋白質去乙醯酶抑制劑之反式醯胺化合物及其使用方法
|
|
EP2571352A4
(en)
|
2010-05-21 |
2014-09-17 |
Sloan Kettering Inst Cancer |
SELECTIVE HDAC HEMMER
|
|
WO2012018499A2
(en)
|
2010-08-05 |
2012-02-09 |
Acetylon Pharmaceuticals |
Specific regulation of cytokine levels by hdac6 inhibitors
|
|
BR112013011868A2
(pt)
|
2010-11-16 |
2016-08-23 |
Acetylon Pharmaceuticals Inc |
compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
|
|
US9512083B2
(en)
|
2011-07-20 |
2016-12-06 |
The General Hospital Corporation |
Histone deacetylase 6 selective inhibitors for the treatment of bone disease
|
|
EP2839037B1
(en)
|
2012-04-19 |
2018-12-26 |
Acetylon Pharmaceuticals, Inc. |
Biomarkers to identify patients that will respond to treatment and treating such patients
|
|
WO2014059306A1
(en)
|
2012-10-12 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
|
JP2016511237A
(ja)
|
2013-02-01 |
2016-04-14 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
選択的ｈｄａｃ３阻害剤
|
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
EP3004141A4
(en)
|
2013-06-03 |
2017-05-31 |
Acetylon Pharmaceuticals, Inc. |
Histone deacetylase ( hdac) biomarkers in multiple myeloma
|
|
JP2016531163A
(ja)
|
2013-09-20 |
2016-10-06 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
Ｈｄａｃ６阻害物質を用いた、異常なリンパ球の機能に起因する疾患の治療
|
|
ES2929576T3
(es)
|
2013-10-08 |
2022-11-30 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
|
|
WO2015054474A1
(en)
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
|
US20150105383A1
(en)
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma
|
|
EP3054954A4
(en)
|
2013-10-10 |
2017-12-13 |
Acetylon Pharmaceuticals, Inc. |
Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
|
|
CA2926808A1
(en)
|
2013-10-11 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Combinations of histone deacetylase inhibitors and immunomodulatory drugs
|
|
US10660890B2
(en)
|
2013-10-24 |
2020-05-26 |
National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) |
Treatment of polycystic diseases with an HDAC6 inhibitor
|
|
CR20160308A
(es)
|
2013-12-03 |
2016-11-08 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
|
|
ES2936812T3
(es)
|
2013-12-20 |
2023-03-22 |
Acetylon Pharmaceuticals Inc |
Biomarcadores de histona desacetilasa 6 (HDAC6) en mieloma múltiple
|
|
US9464073B2
(en)
|
2014-02-26 |
2016-10-11 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
US20150359794A1
(en)
|
2014-06-13 |
2015-12-17 |
Buck Institute For Research On Aging |
Impairment of the large ribosomal subunit protein rpl24 by depletion or acetylation
|
|
SG11201700094TA
(en)
|
2014-07-07 |
2017-02-27 |
Acetylon Pharmaceuticals Inc |
Treatment of leukemia with histone deacetylase inhibitors
|
|
US20160137630A1
(en)
|
2014-10-08 |
2016-05-19 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
|
US9937174B2
(en)
|
2014-12-05 |
2018-04-10 |
University of Modena and Reggio Emilia |
Combinations of histone deacetylase inhibitors and bendamustine
|
|
WO2016090230A1
(en)
|
2014-12-05 |
2016-06-09 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
|
|
AU2015360270B9
(en)
|
2014-12-12 |
2019-12-05 |
Regenacy Pharmaceuticals, Llc |
Piperidine derivatives as HDAC1/2 inhibitors
|
|
US20160339022A1
(en)
|
2015-04-17 |
2016-11-24 |
Acetylon Pharmaceuticals Inc. |
Treatment of neuroblastoma with histone deacetylase inhibitors
|
|
US10272084B2
(en)
|
2015-06-01 |
2019-04-30 |
Regenacy Pharmaceuticals, Llc |
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
|
|
AR105812A1
(es)
|
2015-06-08 |
2017-11-15 |
Acetylon Pharmaceuticals Inc |
Métodos para la preparación de inhibidores de proteína deacetilasa
|